JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
1626
DELISTED
Avantax, Inc. Common Stock
AVTA
| $19.6M | ﹤0.01% |
744,050
-60,398
| -8% | -$1.64M |
|
|
ARNC
1627
DELISTED
Arconic Corporation
ARNC
| $19.6M | ﹤0.01% |
745,941
+86,728
| +13% | +$2.13M |
|
1628
CALL
Berkshire Hathaway Class B
BRK.B
$1.09T
| $19.5M | ﹤0.01% |
63,300
-38,500
| -38% | -$11.9M |
|
1629
NovoCure
NVCR
$2.02B
| $19.5M | ﹤0.01% |
324,944
+14,140
| +5% | +$1.13M |
|
1630
Regal Rexnord
RRX
$11.4B
| $19.5M | ﹤0.01% |
138,683
+20,673
| +18% | +$2.99M |
|
1631
Adient
ADNT
$1.44B
| $19.5M | ﹤0.01% |
475,771
+50,587
| +12% | +$2.11M |
|
1632
iShares Russell Top 200 ETF
IWL
$2.29B
| $19.5M | ﹤0.01% |
200,254
+39,544
| +25% | +$3.72M |
|
1633
DoorDash
DASH
$93.7B
| $19.5M | ﹤0.01% |
306,079
-923,785
| -75% | -$53M |
|
1634
RELX
RELX
$60.4B
| $19.4M | ﹤0.01% |
597,697
+31,983
| +6% | +$959K |
|
1635
MDU Resources
MDU
$4.27B
| $19.4M | ﹤0.01% |
1,670,487
+135,144
| +9% | +$1.57M |
|
1636
CALL
American Tower
AMT
$79.4B
| $19.3M | ﹤0.01% |
94,600
+47,700
| +102% | +$10M |
|
|
CIVI
1637
DELISTED
Civitas Resources
CIVI
| $19.3M | ﹤0.01% |
282,815
-16,093
| -5% | -$1.04M |
|
1638
Kelly Services Class A
KELYA
$566M
| $19.3M | ﹤0.01% |
1,164,908
-5,580
| -0.5% | -$94.9K |
|
1639
CALL
PayPal
PYPL
$51.8B
| $19.3M | ﹤0.01% |
254,400
-1,193,600
| -82% | -$91.9M |
|
1640
Invesco Preferred ETF
PGX
$3.77B
| $19.3M | ﹤0.01% |
1,678,740
+338,235
| +25% | +$4.06M |
|
1641
Vericel Corp
VCEL
$2.29B
| $19.2M | ﹤0.01% |
656,514
-2,262
| -0.3% | -$65.5K |
|
1642
Rollins
ROL
$17.4B
| $19.2M | ﹤0.01% |
511,970
+200,883
| +65% | +$7.25M |
|
1643
PUT
Aon
AON
$75.7B
| $19.2M | ﹤0.01% |
60,900
+38,200
| +168% | +$11.8M |
|
1644
Group 1 Automotive
GPI
$3.14B
| $19.2M | ﹤0.01% |
84,692
-7,867
| -8% | -$1.67M |
|
1645
iShares S&P Small-Cap 600 Value ETF
IJS
$8.43B
| $19.2M | ﹤0.01% |
204,848
-7,011
| -3% | -$685K |
|
1646
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.5B
| $19.1M | ﹤0.01% |
206,428
+7,249
| +4% | +$670K |
|
1647
Bank of N.T. Butterfield & Son
NTB
$2.5B
| $19.1M | ﹤0.01% |
707,571
+241,215
| +52% | +$7.7M |
|
1648
SiriusXM
SIRI
$9.43B
| $19.1M | ﹤0.01% |
481,185
-17,388
| -3% | -$833K |
|
1649
FTI Consulting
FCN
$4.24B
| $19.1M | ﹤0.01% |
96,765
+20,733
| +27% | +$3.6M |
|
1650
PMV Pharmaceuticals
PMVP
$67.2M
| $19.1M | ﹤0.01% |
4,002,884
-93,667
| -2% | -$659K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.